These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 36359761)

  • 21. Inflammatory mediators in the vitreal reflux of patients with diabetic macular edema.
    Cacciamani A; Esposito G; Scarinci F; Parravano M; Dinice L; Di Nicola M; Micera A
    Graefes Arch Clin Exp Ophthalmol; 2019 Jan; 257(1):187-197. PubMed ID: 30377797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current concepts of pharmacotherapy of diabetic macular edema.
    Haritoglou C; Maier M; Neubauer AS; Augustin AJ
    Expert Opin Pharmacother; 2020 Mar; 21(4):467-475. PubMed ID: 31957495
    [No Abstract]   [Full Text] [Related]  

  • 23. Vascular Endothelial Growth Factor and Diabetic Retinal Disease.
    Ajlan RS; Silva PS; Sun JK
    Semin Ophthalmol; 2016; 31(1-2):40-8. PubMed ID: 26959128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial.
    Bressler NM; Beaulieu WT; Glassman AR; Blinder KJ; Bressler SB; Jampol LM; Melia M; Wells JA;
    JAMA Ophthalmol; 2018 Mar; 136(3):257-269. PubMed ID: 29392288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visual outcomes of observation, macular laser and anti-VEGF in diabetic macular edema in type 1 diabetes: a real-world study.
    Wirkkala J; Kubin AM; Ohtonen P; Yliselä J; Siik T; Hautala N
    BMC Ophthalmol; 2022 Jun; 22(1):258. PubMed ID: 35681133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of inflammation in diabetic macular edema and neovascular age-related macular degeneration.
    Vujosevic S; Lupidi M; Donati S; Astarita C; Gallinaro V; Pilotto E
    Surv Ophthalmol; 2024; 69(6):870-881. PubMed ID: 39029747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Burden of diabetic macular oedema in patients receiving antivascular endothelial growth factor therapy in South Korea: a healthcare resource use and cost analysis.
    Jeon HL; Lee H; Yoon D; Lee Y; Kim JH; Jee D; Shin JY
    BMJ Open; 2020 Dec; 10(12):e042484. PubMed ID: 33376178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between Diabetic Retinopathy Severity and Oxygen Metabolism in Patients with Diabetic Macular Edema during Treatment with Intravitreal Aflibercept.
    Blindbæk SL; Peto T; Grauslund J
    Ophthalmic Res; 2020; 63(2):106-113. PubMed ID: 31715608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiology and pharmacological targets of VEGF in diabetic macular edema.
    Fogli S; Mogavero S; Egan CG; Del Re M; Danesi R
    Pharmacol Res; 2016 Jan; 103():149-57. PubMed ID: 26607863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What have we learnt about the management of diabetic macular edema in the antivascular endothelial growth factor and corticosteroid era?
    Agarwal A; Sarwar S; Sepah YJ; Nguyen QD
    Curr Opin Ophthalmol; 2015 May; 26(3):177-83. PubMed ID: 25784111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular Anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathy.
    Simó R; Sundstrom JM; Antonetti DA
    Diabetes Care; 2014 Apr; 37(4):893-9. PubMed ID: 24652720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of micropulse laser combined with ranibizumab in diabetic macular edema treatment: study protocol for a randomized controlled trial.
    Mi X; Gu X; Yu X
    Trials; 2022 Sep; 23(1):736. PubMed ID: 36056443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review on Recent Trials Evaluating the Effect of Intravitreal Injections of Anti-VEGF Agents on the Macular Perfusion of Diabetic Patients with Diabetic Macular Edema.
    Elnahry AG; Abdel-Kader AA; Habib AE; Elnahry GA; Raafat KA; Elrakhawy K
    Rev Recent Clin Trials; 2020; 15(3):188-198. PubMed ID: 32427087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti-Vascular Endothelial Growth Factor Treatment: Outcomes from the Phase 3 Program.
    Do DV; Nguyen QD; Vitti R; Berliner AJ; Gibson A; Saroj N; Soo Y; Boyer DS
    Ophthalmology; 2016 Apr; 123(4):850-7. PubMed ID: 26832658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavior of SD-OCT Detectable Hyperreflective Foci in Diabetic Macular Edema Patients after Therapy with Anti-VEGF Agents and Dexamethasone Implants.
    Rübsam A; Wernecke L; Rau S; Pohlmann D; Müller B; Zeitz O; Joussen AM
    J Diabetes Res; 2021; 2021():8820216. PubMed ID: 33937416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of Cytokines in the Pathogenesis of Diabetic Macular Edema.
    Noma H; Yasuda K; Shimura M
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting compliance to intravitreal anti-vascular endothelial growth factor therapy in Indian patients with retinal vein occlusion, age-related macular degeneration, and diabetic macular edema.
    Kelkar A; Webers C; Shetty R; Kelkar J; Labhsetwar N; Pandit A; Malode M; Tidke S
    Indian J Ophthalmol; 2020 Oct; 68(10):2143-2147. PubMed ID: 32971626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of metabolic parameters on clinical response to VEGF inhibitors for diabetic macular edema.
    Matsuda S; Tam T; Singh RP; Kaiser PK; Petkovsek D; Carneiro G; Zanella MT; Ehlers JP
    J Diabetes Complications; 2014; 28(2):166-70. PubMed ID: 24374138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Saudi Arabia Guidelines for diabetic macular edema: A consensus of the Saudi Retina Group.
    AlQahtani AS; Hazzazi MA; Waheeb SA; Semidey VA; Semidey VA; Elgendy HK; Alkhars WI; Abouammoh MA; Al-Dhibi H
    Saudi Med J; 2021 Feb; 42(2):131-145. PubMed ID: 33563731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VEGF-A gene polymorphisms and responses to intravitreal ranibizumab treatment in patients with diabetic macular edema.
    Tetikoğlu M; Yüksel Z; Aktas S; Sağdik HM; Özcura F
    Int Ophthalmol; 2018 Dec; 38(6):2381-2388. PubMed ID: 29030794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.